Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1961 1
1962 4
1963 3
1965 1
1966 5
1967 3
1968 3
1969 2
1970 3
1971 1
1972 5
1973 3
1974 2
1975 3
1976 4
1977 6
1978 5
1979 9
1980 21
1981 19
1982 15
1983 17
1984 16
1985 23
1986 15
1987 18
1988 17
1989 31
1990 27
1991 25
1992 30
1993 44
1994 48
1995 57
1996 58
1997 96
1998 123
1999 121
2000 203
2001 208
2002 275
2003 317
2004 371
2005 499
2006 612
2007 678
2008 763
2009 894
2010 1144
2011 1273
2012 1402
2013 1448
2014 1554
2015 1759
2016 1820
2017 1790
2018 1783
2019 1854
2020 2046
2021 2234
2022 2007
2023 1937
2024 1982
2025 316

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,440 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Diaz LA Jr, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fourchardiere C, Rivera F, Elez E, Le DT, Yoshino T, Zhong WY, Fogelman D, Marinello P, Andre T; KEYNOTE-177 Investigators. Diaz LA Jr, et al. Among authors: kim tw. Lancet Oncol. 2022 May;23(5):659-670. doi: 10.1016/S1470-2045(22)00197-8. Epub 2022 Apr 12. Lancet Oncol. 2022. PMID: 35427471 Free PMC article. Clinical Trial.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
Fakih MG, Salvatore L, Esaki T, Modest DP, Lopez-Bravo DP, Taieb J, Karamouzis MV, Ruiz-Garcia E, Kim TW, Kuboki Y, Meriggi F, Cunningham D, Yeh KH, Chan E, Chao J, Saportas Y, Tran Q, Cremolini C, Pietrantonio F. Fakih MG, et al. Among authors: kim tw. N Engl J Med. 2023 Dec 7;389(23):2125-2139. doi: 10.1056/NEJMoa2308795. Epub 2023 Oct 22. N Engl J Med. 2023. PMID: 37870968 Clinical Trial.
PIEZO-dependent mechanosensing is essential for intestinal stem cell fate decision and maintenance.
Baghdadi MB, Houtekamer RM, Perrin L, Rao-Bhatia A, Whelen M, Decker L, Bergert M, Pérez-Gonzàlez C, Bouras R, Gropplero G, Loe AKH, Afkhami-Poostchi A, Chen X, Huang X, Descroix S, Wrana JL, Diz-Muñoz A, Gloerich M, Ayyaz A, Matic Vignjevic D, Kim TH. Baghdadi MB, et al. Among authors: kim th. Science. 2024 Nov 29;386(6725):eadj7615. doi: 10.1126/science.adj7615. Epub 2024 Nov 29. Science. 2024. PMID: 39607940
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer.
You E, Danaher P, Lu C, Sun S, Zou L, Phillips IE, Rojas AS, Ho NI, Song Y, Raabe MJ, Xu KH, Richieri PM, Li H, Aston N, Porter RL, Patel BK, Nieman LT, Schurman N, Hudson BM, North K, Church SE, Deshpande V, Liss AS, Kim TK, Cui Y, Kim Y, Greenbaum BD, Aryee MJ, Ting DT. You E, et al. Among authors: kim tk. Cell. 2024 Dec 12;187(25):7232-7247.e23. doi: 10.1016/j.cell.2024.09.024. Epub 2024 Oct 8. Cell. 2024. PMID: 39383862
Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis.
Kim SM, Park S, Hwang SH, Lee EY, Kim JH, Lee GS, Lee G, Chang DH, Lee JG, Hwang J, Lee Y, Kyung M, Kim EK, Kim JH, Kim TH, Moon JH, Kim BC, Ko G, Kim SY, Ryu JH, Lee JS, Lee CH, Kim JY, Kim S, Lee WJ, Kim MH. Kim SM, et al. Among authors: kim th. Cell Host Microbe. 2023 Jun 14;31(6):1021-1037.e10. doi: 10.1016/j.chom.2023.05.007. Epub 2023 Jun 2. Cell Host Microbe. 2023. PMID: 37269833 Free article.
Understanding CD4+ T cells in autoimmune bullous diseases.
Lee AY, Kim T, Kim JH. Lee AY, et al. Among authors: kim t. Front Immunol. 2023 Apr 17;14:1161927. doi: 10.3389/fimmu.2023.1161927. eCollection 2023. Front Immunol. 2023. PMID: 37138879 Free PMC article. Review.
Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meeting.
Sun J, Ince MN, Abraham C, Barrett T, Brenner LA, Cong Y, Dashti R, Dudeja PK, Elliott D, Griffith TS, Heeger PS, Hoisington A, Irani K, Kim TK, Kapur N, Leventhal J, Mohamadzadeh M, Mutlu E, Newberry R, Peled JU, Rubinstein I, Sengsayadeth S, Tan CS, Tan XD, Tkaczyk E, Wertheim J, Zhang ZJ. Sun J, et al. Among authors: kim tk. Gut Microbes. 2023 Dec;15(2):2267180. doi: 10.1080/19490976.2023.2267180. Epub 2023 Oct 16. Gut Microbes. 2023. PMID: 37842912 Free PMC article.
Exercise molecule burns away hunger.
Kim T, Sternson SM. Kim T, et al. Nature. 2022 Jun;606(7915):655-656. doi: 10.1038/d41586-022-01321-x. Nature. 2022. PMID: 35705863 No abstract available.
Rare disease genomics and precision medicine.
Hong J, Lee D, Hwang A, Kim T, Ryu HY, Choi J. Hong J, et al. Among authors: kim t. Genomics Inform. 2024 Dec 3;22(1):28. doi: 10.1186/s44342-024-00032-1. Genomics Inform. 2024. PMID: 39627904 Free PMC article. Review.
Peptide-Based Prodrug Approaches for Cancer Nanomedicine.
Khaliq NU, Amin L, Khaliq SU, Amin A, Omer S, Khaliq IU, Kim Y, Kim J, Kim T, Seo D, Sung D, Kim H. Khaliq NU, et al. Among authors: kim t. ACS Appl Bio Mater. 2024 Dec 16;7(12):8163-8176. doi: 10.1021/acsabm.4c01364. Epub 2024 Nov 27. ACS Appl Bio Mater. 2024. PMID: 39601471 Review.
28,440 results
You have reached the last available page of results. Please see the User Guide for more information.